Biologics in Sinonasal Disease

Biologics in Sinonasal Disease

Introduction: This is a case-based learning activity designed to outline the workup and management of patients with chronic rhinosinusitis with polyps, with an emphasis on the role of biologic therapies (e.g. dupilumab and omalizumab) in patients with more severe disease and/or refractory to other management strategies.

Purpose/Abstract: The participant who has successfully completed this program should be able to:
1. Differentiate the symptoms and physical examination findings that distinguish chronic rhinosinusitis with nasal polyps from other common nasal diseases.
2. Discuss the typical treatment algorithm for chronic rhinosinusitis with nasal polyps.
3. Discuss the treatment options for patients that fail initial surgery for chronic rhinosinusitis with nasal polyps.
4. Discuss the mechanism of action, indications, side effects and efficacy of biologic therapies used in the management of chronic rhinosinusitis with nasal polyps.

  • Provider:American Academy of Otolaryngology – Head & Neck Surgery Foundation
  • Activity Link: https://academyu.entnet.org/diweb/catalog/item/id/9399023
  • Start Date: 2022-06-06 05:00:00
  • End Date: 2022-06-06 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • MOC Credit Details: ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Community/Population Health, Learner Competence, Learner Knowledge, Learner Performance, Patient Health
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Allergy, General Otolaryngology, Rhinology
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.